Deutsche Bank Ag\ Vertex Pharmaceuticals Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,312,910 shares of VRTX stock, worth $536 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,312,910

Previous 1,379,320 4.81%

Holding current value

$536 Million

Previous $647 Million 5.55%

% of portfolio

0.25%

Previous 0.3%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $30.5 Million - $33.6 Million	-66,410 Reduced 4.81%	1,312,910 $611 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $77.6 Million - $95.9 Million	-197,541 Reduced 12.53%	1,379,320 $647 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $28.5 Million - $31.1 Million	-69,804 Reduced 4.24%	1,576,861 $659 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $110 Million - $132 Million	320,297 Added 24.15%	1,646,665 $670 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $91.4 Million - $97.9 Million	-270,232 Reduced 16.93%	1,326,368 $461 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $50.2 Million - $56.2 Million	-159,560 Reduced 9.09%	1,596,600 $562 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $27.5 Million - $31.3 Million	-96,922 Reduced 5.23%	1,756,160 $553 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $7.32 Million - $8.24 Million	25,625 Added 1.4%	1,853,082 $535 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $58.5 Million - $65.3 Million	-213,715 Reduced 10.47%	1,827,457 $529 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $25.2 Million - $31.4 Million	-107,454 Reduced 5.0%	2,041,172 $575 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $90.9 Million - $107 Million	-410,687 Reduced 16.05%	2,148,626 $561 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $22.5 Million - $28.4 Million	-127,278 Reduced 4.74%	2,559,313 $562 Million
Q3 2021 Nov 04, 2021	SELL	$181.39 - $202.99 $8.58 Million - $9.61 Million	-47,319 Reduced 1.73%	2,686,591 $487 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $130 Million - $154 Million	694,871 Added 34.08%	2,733,910 $551 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $162 Million - $189 Million	783,218 Added 62.37%	2,039,039 $438 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $48.9 Million - $65.2 Million	236,046 Added 23.15%	1,255,821 $297 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $29.8 Million - $35.4 Million	116,703 Added 12.92%	1,019,775 $278 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $8.17 Million - $10.7 Million	-36,239 Reduced 3.86%	903,072 $262 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $106 Million - $132 Million	-532,686 Reduced 36.19%	939,311 $224 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $1.29 Million - $1.73 Million	-7,738 Reduced 0.52%	1,471,997 $322 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $53.3 Million - $60 Million	-320,786 Reduced 17.82%	1,479,735 $251 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $66.5 Million - $76.9 Million	403,803 Added 28.91%	1,800,521 $330 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $70.8 Million - $84.2 Million	432,709 Added 44.89%	1,396,718 $257 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $50.6 Million - $64 Million	-332,854 Reduced 25.67%	964,009 $160 Million
Q3 2018 Dec 21, 2021	BUY	$167.73 - $192.74 $75.4 Million - $86.6 Million	449,387 Added 53.03%	1,296,863 $250 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $89.5 Million - $103 Million	-533,749 Reduced 38.64%	847,476 $163 Million
Q2 2018 Apr 21, 2020	BUY	$145.72 - $169.96 $54.8 Million - $63.9 Million	375,877 Added 37.39%	1,381,225 $235 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $48.7 Million - $56.8 Million	-334,333 Reduced 24.96%	1,005,348 $171 Million
Q1 2018 Oct 18, 2019	BUY	$151.6 - $177.13 $91.5 Million - $107 Million	603,393 Added 81.95%	1,339,681 $218 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $29.7 Million - $34.8 Million	-196,189 Reduced 21.04%	736,288 $120 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $8.14 Million - $9.23 Million	-59,309 Reduced 5.98%	932,477 $140 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $147 Million - $161 Million	991,786	991,786 $151 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account